Willow Biosciences Inc (CANSF)
0.097
+0.02
(+29.33%)
USD |
OTCM |
May 31, 16:00
Willow Biosciences Max Drawdown (5Y): 98.71% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 98.71% |
April 30, 2024 | 98.71% |
March 31, 2024 | 98.71% |
February 29, 2024 | 98.71% |
January 31, 2024 | 98.71% |
December 31, 2023 | 98.71% |
November 30, 2023 | 98.71% |
October 31, 2023 | 98.71% |
September 30, 2023 | 98.71% |
August 31, 2023 | 98.71% |
July 31, 2023 | 98.71% |
June 30, 2023 | 98.71% |
May 31, 2023 | 98.71% |
April 30, 2023 | 98.71% |
March 31, 2023 | 98.71% |
February 28, 2023 | 98.71% |
January 31, 2023 | 98.71% |
December 31, 2022 | 98.71% |
November 30, 2022 | 98.71% |
October 31, 2022 | 98.71% |
September 30, 2022 | 98.71% |
August 31, 2022 | 98.71% |
July 31, 2022 | 98.71% |
June 30, 2022 | 98.71% |
May 31, 2022 | 98.71% |
Date | Value |
---|---|
April 30, 2022 | 98.71% |
March 31, 2022 | 98.71% |
February 28, 2022 | 98.71% |
January 31, 2022 | 98.71% |
December 31, 2021 | 98.71% |
November 30, 2021 | 98.71% |
October 31, 2021 | 98.71% |
September 30, 2021 | 98.71% |
August 31, 2021 | 99.48% |
July 31, 2021 | 99.48% |
June 30, 2021 | 99.48% |
May 31, 2021 | 99.48% |
April 30, 2021 | 99.48% |
March 31, 2021 | 99.48% |
February 28, 2021 | 99.48% |
January 31, 2021 | 99.48% |
December 31, 2020 | 99.48% |
November 30, 2020 | 99.48% |
October 31, 2020 | 99.48% |
September 30, 2020 | 99.48% |
August 31, 2020 | 99.48% |
July 31, 2020 | 99.48% |
June 30, 2020 | 99.48% |
May 31, 2020 | 99.48% |
April 30, 2020 | 99.48% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.71%
Minimum
Sep 2021
99.48%
Maximum
Jun 2019
99.06%
Average
98.71%
Median
Sep 2021
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -57.20 |
Beta (5Y) | 1.241 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.63% |
Historical Sharpe Ratio (5Y) | -0.4587 |
Historical Sortino (5Y) | -1.136 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.41% |